Europe’s medicines regulator confirmed that leukoencephalopathy is a rare but serious side effect of levamisole-containing medicines. Medscape News Europe Source link : https://www.medscape.com/viewarticle/eu-withdrawal-levamisole-recommended-due-cns-risks-2026a10004pl?src=rss Author : Publish date : 2026-02-13 15:47:00...
Read more











